ArticleCureus2025
Clinical Profile of Polycystic Ovarian Syndrome in Women From Bhimavaram: A Cross-Sectional Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Polycystic ovarian syndrome (PCOS) is a complex endocrinological dysfunction that affects the hypothalamic-pituitary-ovarian axis. Despite its high prevalence, variations in phenotypic presentation and associated risk factors remain underexplored. The study aims to identify the prevalence, biochemical, clinical, and hormonal features of PCOS women, emphasizing phenotype classification and therapeutic interventions. Methods This cross-sectional, prospective multi-centre study was conducted in outpatient gynaecology clinics in Bhimavaram, India, from July 2019 to December 2023. Participants were diagnosed based on the Rotterdam criteria and classified into phenotypes A, B, C, and D. Data on socio-demographics, clinical manifestations, hormonal profiles, and treatment adherence were collected and analysed using Epi Info (version 7.2.6.0; Centers for Disease Control and Prevention, Atlanta, GA). Associations between phenotypes and metabolic profiles were assessed using analysis of variance (ANOVA) and chi-square tests. Results Among the study population, 403 (8.02%) were diagnosed with PCOS, with phenotype C in 139 (40.76%) being the most prevalent, followed by phenotypes D (n=90, 26.39%), A (n=89, 26.10%), and B (n=23, 6.74%), respectively. Oligomenorrhoea was a frequent menstrual disturbance found in 145 women (42.52%). Acne was experienced by 191 participants (56.01%), and hirsutism was seen in 182 (53.32%), signifying them as common hyperandrogenic symptoms. It is also noted that a significant proportion of the study population was overweight or obese (n=162, 47.5%). Anaemia was observed in 268 participants (78.6%), while 71 (20.82%) women had hypothyroidism, and 14 (4.11%) were diabetic. Therapeutic management included clomiphene citrate, hormonal contraceptives, and metformin. However, adherence remained a key challenge in achieving therapeutic success. Conclusion With the increase in the prevalence rate, early diagnosis and lifestyle modifications are required to prevent long-term complications in women. Additionally, risk factors identified in this study can be modified with appropriate interventions and preventive measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.